Safety Indicators in the STRONG-HF Trial From a Methodological Perspective

Xavier Rossello1

  • 1Cardiology Department, Hospital Universitari Son Espases, Palma, Spain; Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain; Facultad de Medicina, Universitat de les Illes Balears (UIB), Palma, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Journal of Cardiac Failure
|February 23, 2024
PubMed
Summary

No abstract available in PubMed .